Loading clinical trials...
Loading clinical trials...
An Open-label, Multicenter, Randomized, Phase 3 Trial to Assess the Efficacy and Safety of Coinfusion With Unrelated Cord Blood Unit for Patients With Acute Myeloid Leukemia Undergoing Haploidentical Hematopoietic Cell Transplantation
Conditions
Interventions
haplo-HCT
haplo-cord HCT
Locations
5
China
The Second People's Hospital of Huai'an
Huai'an, Jiangsu, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Soochow Hopes Hematology Hospital
Suzhou, Jiangsu, China
Hygeia Suzhou Yongding Hospital
Suzhou, Jiangsu, China
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Start Date
June 1, 2017
Primary Completion Date
December 31, 2022
Completion Date
March 31, 2023
Last Updated
June 27, 2023
NCT06093867
NCT05436418
NCT07101588
NCT04146870
NCT07244419
NCT06494423
Lead Sponsor
The First Affiliated Hospital of Soochow University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions